Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
Inability to balance on one leg in middle age tied to premature death
Jun 23, 2022
“There is potential benefit to including the 10-second, one-legged stance as part of routine physical examination in middle-aged and older adults,” the authors write.
Certain antihypertensive agents may aid cognition in elderly
Jun 21, 2021
Memory recall is better for up to three years with blood-brain barrier-crossing renin-angiotensin drugs versus nonpenetrant counterparts.
10 percent of U.S. adults meet vegetable intake recommendations
Jan 07, 2022
12.3% meet fruit intake recommendations, ranging from 8.4 to 16.1% in West Virginia and Connecticut.
Many U.S. adults report pandemic-related sleep disturbances
Jan 03, 2022
Overall, 56% of respondents have experienced “COVID-somnia” sleep disturbances; this number was slightly higher among younger people versus older adults.
Colorectal cancer risk up for patients with psoriasis
Nov 30, 2021
In a subgroup analysis according to sex, an increased risk for CRC was seen for female but not male psoriasis patients.
Unhealthy lifestyle increases risk for nursing home admissions
Aug 29, 2023
The findings were seen for adults aged 60 or more years who were followed for 11.3 years, with doubled the risk in those aged 60 to 64 years in the high-risk lifestyle group.
Caregivers more likely to have subjective cognitive decline
Nov 19, 2021
“Healthcare professionals can support their patients and their patients’ caregivers by recognizing SCD and its associated challenges in providing care and providing compensatory strategies...
New COVID-19 variant XBB gaining ground among Americans
Nov 28, 2022
The new omicron subvariant is taking hold in the United States, health officials say, although it does not look more severe than its predecessors.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.